CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
CEL SCI CORP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.14 (-7.82%)
Close on Oct 19, 2026
- Market cap
- $19.99M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
11.3%
2M of 18M shares
Institutional holders
41
10 new, 7 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $867.00K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 555,000 | 6.94% | 13G (passive) | Aug 27, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CVM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 572,460 | 3.25% | $595.36K | +536,570 | 0.00% |
| Vanguard Capital Management LLC | 543,079 | 3.09% | $564.80K | +299,434 | 0.00% |
| Citadel Advisors LLC | 198,500 | 1.13% | $206.44K | New | 0.00% |
| MAI Capital Management | 108,280 | 0.62% | $112.61K | +17,000 | 0.00% |
| Geode Capital Management, LLC | 88,200 | 0.50% | $91.78K | +2,889 | 0.00% |
| Commonwealth Equity Services, LLC | 51,434 | 0.29% | $53.49K | +33,812 | 0.00% |
| Hrt Financial LP | 51,155 | 0.29% | $53 | New | 0.00% |
| Vanguard Fiduciary Trust Co | 49,036 | 0.28% | $51.00K | – | 0.00% |
| BlackRock, Inc. | 43,261 | 0.25% | $44.99K | – | 0.00% |
| Bank Of America Corp /De/ | 40,916 | 0.23% | $42.55K | −81 | 0.00% |
| Jane Street Group, LLC | 36,458 | 0.21% | $37.92K | New | 0.00% |
| XTX Topco Ltd | 34,888 | 0.20% | $36.28K | +12,332 | 0.00% |
| Osaic Holdings, Inc. | 32,780 | 0.19% | $34.08K | +30,897 | 0.00% |
| US Bancorp \de\ | 29,907 | 0.17% | $31.10K | – | 0.00% |
| State Street Corp | 27,270 | 0.16% | $28.36K | – | 0.00% |
| Northern Trust Corp | 21,083 | 0.12% | $21.93K | +2,149 | 0.00% |
| Raymond James Financial Inc | 16,013 | 0.09% | $16.65K | New | 0.00% |
| Virtu Financial LLC | 11,315 | 0.06% | $12 | New | 0.00% |
| Financial Consulate, Inc | 10,000 | 0.06% | $10.40K | New | 0.00% |
| HighTower Advisors, LLC | 10,000 | 0.06% | $10.40K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 41 | 2M | 11.3% | 10 / 10 | 3 / 7 | 1M | 0M |
| Q1 2026 | 38 | 1M | 4.2% | 5 / 11 | 4 / 6 | 0M | 0M |
| Q4 2025 | 40 | 1M | 4.2% | 10 / 10 | 8 / 5 | 0M | 0M |
| Q3 2025 | 35 | 1M | 5.0% | 8 / 7 | 8 / 1 | 0M | 0M |
| Q2 2025 | 28 | 0M | 2.7% | 28 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CVM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 456,941 | 2.60% | $475.22K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 86,138 | 0.49% | $89.58K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 42,461 | 0.24% | $65.39K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 12,164 | 0.07% | $18.73K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 11,520 | 0.07% | $17.74K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 7,500 | 0.04% | $7.80K | 0.01% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 45 | 0.00% | $47 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Geert R. Kersten | Chief Executive Officer, Director | 627,689 | 3.57% | Aug 26, 2026 |
| Patricia B. Prichep | Chief Financial Officer | 17,489 | 0.10% | Aug 17, 2026 |
| John Cipriano | Senior Vice President | 63,108 | 0.36% | Aug 17, 2026 |
| Eyal Talor | Chief Scientific Officer | 9,318 | 0.05% | Aug 17, 2026 |
| Robert Eugene Watson | Director | 3,733 | 0.02% | Aug 17, 2026 |
| Bruno Jean-Marie Baillavoine | Director | 5,973 | 0.03% | Aug 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Geert R. Kersten Chief Executive Officer, Director | Aug 25, 2026 | Buy | +100,000 | $1.38 | $138.00K | 316,142 |
| Geert R. Kersten Chief Executive Officer, Director | Jun 30, 2026 | Award | +5,192 | $1.04 | $5.40K | 216,142 |
| Eyal Talor Chief Scientific Officer | Jun 30, 2026 | Award | +2,307 | $1.04 | $2.40K | 9,318 |
| Patricia B. Prichep Chief Financial Officer | Jun 30, 2026 | Award | +4,125 | $1.04 | $4.29K | 17,489 |
| Geert R. Kersten Chief Executive Officer, Director | May 14, 2026 | Buy | +300,000 | $1.20 | $360.00K | 311,547 |
| Geert R. Kersten Chief Executive Officer, Director | May 13, 2026 | Buy | +100,000 | $1.19 | $119.00K | 222,497 |
| Eyal Talor Chief Scientific Officer | Mar 31, 2026 | Award | +747 | $3.21 | $2.40K | 7,011 |
| Patricia B. Prichep Chief Financial Officer | Mar 31, 2026 | Award | +1,336 | $3.21 | $4.29K | 13,364 |
| Geert R. Kersten Chief Executive Officer, Director | Mar 31, 2026 | Award | +1,682 | $3.21 | $5.40K | 122,497 |
| Geert R. Kersten Chief Executive Officer, Director | Jan 22, 2026 | Buy | +38,023 | $5.26 | $200.00K | 120,815 |
| Geert R. Kersten Chief Executive Officer, Director | Dec 31, 2025 | Award | +998 | $5.26 | $5.25K | 82,792 |
| Patricia B. Prichep Chief Financial Officer | Dec 31, 2025 | Award | +815 | $5.26 | $4.29K | 12,028 |
| Eyal Talor Chief Scientific Officer | Dec 31, 2025 | Award | +456 | $5.26 | $2.40K | 6,264 |
| Geert R. Kersten Chief Executive Officer, Director | Dec 4, 2025 | Buy | +8,389 | $5.96 | $50.00K | 81,794 |
| Geert R. Kersten Chief Executive Officer, Director | Sep 30, 2025 | Award | +570 | $9.20 | $5.24K | 73,405 |
| Patricia B. Prichep Chief Financial Officer | Sep 30, 2025 | Award | +466 | $9.20 | $4.29K | 11,213 |
| Eyal Talor Chief Scientific Officer | Sep 30, 2025 | Award | +260 | $9.20 | $2.39K | 5,808 |
| Robert Eugene Watson Director | Jul 25, 2025 | Buy | +2,919 | $6.85 | $20.00K | 3,733 |
| Geert R. Kersten Chief Executive Officer, Director | Jul 25, 2025 | Buy | +29,197 | $6.85 | $200.00K | 72,835 |
| Patricia B. Prichep Chief Financial Officer | Jun 30, 2025 | Award | +1,873 | $2.29 | $4.29K | 10,747 |
| Eyal Talor Chief Scientific Officer | Jun 30, 2025 | Award | +1,048 | $2.29 | $2.40K | 5,548 |
| Geert R. Kersten Chief Executive Officer, Director | Jun 30, 2025 | Award | +2,292 | $2.29 | $5.25K | 43,638 |
| Eyal Talor Chief Scientific Officer | Mar 31, 2025 | Award | +10,416 | $0.23 | $2.40K | 135,013 |
| Geert R. Kersten Chief Executive Officer, Director | Mar 31, 2025 | Award | +22,786 | $0.23 | $5.24K | 1,240,378 |
| Patricia B. Prichep Chief Financial Officer | Mar 31, 2025 | Award | +15,432 | $0.23 | $3.55K | 266,230 |
| Eyal Talor Chief Scientific Officer | Dec 31, 2024 | Award | +6,001 | $0.40 | $2.40K | 124,597 |
| Geert R. Kersten CEO, Director | Dec 31, 2024 | Award | +12,940 | $0.40 | $5.18K | 1,217,592 |
| Patricia B. Prichep Chief Financial & Operations | Dec 31, 2024 | Award | +10,727 | $0.40 | $4.29K | 250,798 |
| Geert R. Kersten Chief Executive Officer, Director | Sep 30, 2024 | Award | +4,882 | $1.06 | $5.17K | 1,204,652 |
| Eyal Talor Chief Scientific Officer | Sep 30, 2024 | Award | +2,264 | $1.06 | $2.40K | 118,596 |
| Patricia B. Prichep Sr. VP of Operations | Sep 30, 2024 | Award | +4,047 | $1.06 | $4.29K | 240,071 |
| Geert R. Kersten Chief Executive Officer, Director | Jun 28, 2024 | Award | +4,461 | $1.16 | $5.17K | 1,199,770 |
| Eyal Talor Chief Scientific Officer | Jun 28, 2024 | Award | +2,068 | $1.16 | $2.40K | 116,332 |
| Patricia B. Prichep Senior Vice President | Jun 28, 2024 | Award | +3,698 | $1.16 | $4.29K | 236,024 |
| Robert Eugene Watson Director | May 8, 2024 | Buy | +20,000 | $1.39 | $27.80K | 24,431 |
| Patricia B. Prichep Senior Vice President | May 8, 2024 | Buy | +8,000 | $1.39 | $11.12K | 232,326 |
| Geert R. Kersten Chief Executive Officer, Director | May 8, 2024 | Buy | +30,000 | $1.39 | $41.70K | 1,195,309 |
| Geert R. Kersten Chief Executive Officer, Director | Mar 29, 2024 | Award | +2,709 | $1.91 | $5.17K | 1,165,309 |
| Patricia B. Prichep Senior Vice President | Mar 29, 2024 | Award | +2,246 | $1.91 | $4.29K | 224,326 |
| Eyal Talor Chief Scientific Officer | Mar 29, 2024 | Award | +1,256 | $1.91 | $2.40K | 114,264 |
| Geert R. Kersten Chief Executive Officer, Director | Dec 29, 2023 | Award | +1,819 | $2.72 | $4.95K | 1,162,600 |
| Patricia B. Prichep Senior Vice President | Dec 29, 2023 | Award | +1,577 | $2.72 | $4.29K | 222,080 |
| Eyal Talor Chief Scientific Officer | Dec 29, 2023 | Award | +882 | $2.72 | $2.40K | 113,008 |
| Patricia B. Prichep Senior Vice President | Sep 29, 2023 | Award | +3,432 | $1.25 | $4.29K | 220,503 |
| Geert R. Kersten Chief Executive Officer, Director | Sep 29, 2023 | Award | +3,960 | $1.25 | $4.95K | 1,160,781 |
| Eyal Talor Chief Scientific Officer | Sep 29, 2023 | Award | +1,920 | $1.25 | $2.40K | 112,126 |
| Patricia B. Prichep Senior Vice President | Jun 30, 2023 | Award | +1,780 | $2.41 | $4.29K | 217,071 |
| Geert R. Kersten Chief Executive Officer, Director | Jun 30, 2023 | Award | +2,053 | $2.41 | $4.95K | 1,156,821 |
| Eyal Talor Chief Scientific Officer | Jun 30, 2023 | Award | +995 | $2.41 | $2.40K | 110,206 |
| Geert R. Kersten Chief Executive Officer, Director | Mar 31, 2023 | Award | +2,133 | $2.32 | $4.95K | 1,154,768 |
| Patricia B. Prichep Senior Vice President | Mar 31, 2023 | Award | +1,849 | $2.32 | $4.29K | 215,291 |
| Eyal Talor Chief Scientific Officer | Mar 31, 2023 | Award | +1,034 | $2.32 | $2.40K | 109,211 |
| Patricia B. Prichep Senior Vice President | Dec 30, 2022 | Award | +1,825 | $2.35 | $4.29K | 213,442 |
| Geert R. Kersten Chief Executive Officer, Director | Dec 30, 2022 | Award | +1,851 | $2.35 | $4.35K | 1,152,635 |
| Eyal Talor Chief Scientific Officer | Dec 30, 2022 | Award | +1,021 | $2.35 | $2.40K | 108,177 |
| Daniel H. Zimmerman Senior Vice President | Sep 30, 2022 | Award | +1,266 | $3.09 | $3.91K | 120,226 |
| Eyal Talor Chief Scientific Officer | Sep 30, 2022 | Award | +776 | $3.09 | $2.40K | 107,156 |
| Patricia B. Prichep Senior Vice President | Sep 30, 2022 | Award | +1,388 | $3.09 | $4.29K | 211,617 |
| Geert R. Kersten Chief Executive Officer, Director | Sep 30, 2022 | Award | +1,407 | $3.09 | $4.35K | 1,150,784 |
| Eyal Talor Chief Scientific Officer | Jun 30, 2022 | Award | +533 | $4.50 | $2.40K | 106,380 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.